Medicines Reimaged, the International Drug Repurposing Conference 2025 (#iDR25) hosted by REMEDi4ALL and Beacon aims to unlock the full potential of medicines by driving innovation for patient benefit. This global event will explore how cutting-edge artificial intelligence (AI) approaches are transforming drug discovery, alongside innovative business models and regulatory pathways for market access. You’ll engage with key opinion leaders across research and patient communities, policymakers, funders, regulators and the private sector.

Discover how funders are shaping the future of drug repurposing and explore real-life examples. Together with others who are passionate about the transformative potential of medicines, this is your chance to connect, innovate and reshape drug repurposing.

The agenda features thought-provoking plenaries, expert discussions and sessions on AI in clinical decision-making, new opportunities in drug repurposing, and addressing the needs of underserved populations – including rare diseases, rare cancers, and paediatric and rare infectious conditions. We’ll also dive into innovative trial designs, policy, and pathways to improve patient access.

Explore cutting-edge insights, discuss challenges, and engage with leading experts. Find out more about the speakers, location, ticket prices and more here.